Elite Pharmaceuticals unveils positive top-line data from key bio-equivalence study for undisclosed antibiotic generic drug
Elite Pharmaceuticals Inc (OTCBB:ELTP), a pharmaceutical group that develops abuse-deterrent opioids and niche generic drugs, has unveiled positive top-line results from key bio-equivalence studies conducted for an undisclosed antibiotic generic drug now being co-developed with SunGen Pharma.
The top-line results show that the generic product is bio-equivalent to its branded product in studies where patients either fasted or were fed.
The studies were open-label, randomized, single oral dose, bio-equivalence studies evaluating healthy adult volunteers in both the fed and fasted states.
Read: Elite Pharmaceuticals reports sharp drop in revenue in fiscal 2018 due to sluggish sales of methadone
The filing of an abbreviated new drug application for the undisclosed drug is expected before the close of the year.
“I am pleased we have achieved this milestone and are expected to file this [abbreviated new drug application] by year-end,” said Elite CEO Nasrat Hakim.
“Elite continues to build a strong pipeline by combining its own products with those co-developed with SunGen,” he added.
Read: Elite Pharmaceuticals Inc surges on FDA milestone for SequestOX
Based in Northvale, New Jersey, Elite Pharmaceuticals bills itself as a specialty pharmaceutical company which is developing a pipeline of abuse-deterrent opioid products as well as niche generic drugs. Elite owns generic and OTC (over the counter) products which have been licensed to TAGI Pharma, Epic Pharma, Glenmark Pharmaceuticals and Dr. Reddy’s Laboratories.
Its partner SunGen Pharma, which is headquartered in Princeton, New Jersey, meanwhile, focuses on the development of high-quality generic drugs and has over forty products under development at various stages that either have been or will be filed with the US Food and Drug Administration.
Elite shares were up 1.7% at US$0.10 in afternoon trade.
Contact Ellen Kelleher at [email protected]
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/202888/elite-pharmaceuticals-unveils-positive-top-line-data-from-key-bio-equivalence-study-for-undisclosed-antibiotic-generic-drug-202888.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).